Key facts
- Notable investors include GrowthX Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Cognivue (Diagnostic Equipment)
- ·The full record, as it builds
Funding rounds
No funding rounds for Cognivue (Diagnostic Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cognivue (Diagnostic Equipment)
Developer and manufacturer of a risk assessment test designed to identify changes in cognitive function. The company's self-administered computerized assessment evaluates cognitive domains for visuospatial, executive function/attention, naming/language, memory, delayed recall, and abstraction with two-speed performance parameters, reaction time, and speed processing, enabling healthcare professionals to detect dementia or Alzheimer's disease.
- Sector
- Healthcare
- HQ
- Victor, NY, United States
- Founded
- 2018
- Employees
- 31
- Website
- cognivue.com/
- Ownership
- Privately Held (backing)
Cognivue (Diagnostic Equipment) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cognivue (Diagnostic Equipment) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cognivue (Diagnostic Equipment) in its N-PORT filings yet. We sweep new filings monthly.